Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
RadNet, Inc.

RadNet, Inc. (RDNT) Stock Overview

Explore RadNet, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RDNT●NASDAQ
HealthcareMedical - Diagnostics & Research
$76.82
$0.23(0.30%)
U.S. Market opens in 64h 50m

RadNet, Inc. (RDNT)

Meyka AI Score

Z

Key Financials

Market Cap6B
P/E Ratio-291.97
EPS (TTM)$0.46
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$85.95
3 Months$83.73
1 Year Target$83.61

RDNT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of RadNet, Inc. (NASDAQ: RDNT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, RadNet, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RDNT on the NASDAQ shows an RSI of 68.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $83.61 for the NASDAQ listing.

Key metrics behind RadNet, Inc.'s NASDAQ-traded stock include a P/E ratio of -291.97 and a market capitalization of 6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RDNT on the NASDAQ.

Price Performance (NASDAQ: RDNT)

1-Day Change
-0.30%
5-Day Change
-0.07%
1-Month Change
24.16%
3-Month Change
41.11%
6-Month Change
9.62%
Year-to-Date (YTD) Change
7.67%
1-Year Change
11.97%
3-Year Change
151.54%
5-Year Change
152.37%
All-Time (Max) Change
10281.08%

Contact Information

https://www.radnet.com
310 478 7808
1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025

Company Facts

90,600 Employees
IPO DateJan 3, 1997
CountryUS
Actively Trading

Frequently Asked Questions